Chronic Myelomonocytic Leukemia
Chronic Myelomonocytic Leukemia (CMML) is a rare blood cancer affecting the bone marrow and blood cells, leading to abnormal production of monocytes.
Symptoms may develop slowly and include fatigue, fever, weight loss, or infections. Timely diagnosis is crucial to monitor disease progression and determine the appropriate treatment plan, which may involve chemotherapy, targeted therapy, or stem cell transplantation.
Causes and Risk Factors of CMML
The exact cause of CMML is unknown, but certain factors may increase risk.
- Age factor: Most commonly diagnosed in adults over 60 years old.
- Genetic mutations affecting blood cell production.
- Previous chemotherapy or radiation exposure may contribute.
Symptoms and Clinical Presentation
CMML symptoms can be subtle initially and progress gradually over time.
- Fatigue and weakness
- Unexplained fever or night sweats
- Enlarged spleen: Causing abdominal discomfort or fullness
- Frequent infections due to immune compromise
Treatment Options for CMML
Treatment depends on age, overall health, and disease progression. Options include:
- Chemotherapy: To reduce abnormal monocyte counts and control symptoms.
- Targeted therapy: Drugs aimed at specific genetic mutations in CMML cells.
- Stem cell transplantation: Considered in eligible patients for long-term disease control.
Why Choose Us for CMML
CureU Healthcare offers experienced hematology-oncology specialists, advanced diagnostics, and individualized treatment plans for patients with CMML.
Conclusion
CMML is a rare, slowly progressing blood cancer. Early diagnosis and personalized treatment at CureU Healthcare improve outcomes and patient quality of life.
